Buch, Englisch, 330 Seiten, Format (B × H): 191 mm x 235 mm
From Computational Modeling to Precision Cancer Care
Buch, Englisch, 330 Seiten, Format (B × H): 191 mm x 235 mm
ISBN: 978-0-443-55755-2
Verlag: Elsevier Science
Computational Biology in Oncology: From Computational Modeling to Precision Cancer Care presents a comprehensive exploration of cancer digital twins as dynamic, patient-specific computational models that support precision oncology. The book examines how computational biology, artificial intelligence, and multimodal clinical data can be integrated to improve cancer diagnosis, treatment planning, and patient outcomes. The book covers the conceptual foundations of oncology digital twins, including data integration, computational modeling, machine learning, radiomics, digital pathology, multi-omics, and longitudinal patient monitoring. It further explores applications across the cancer care continuum, from risk stratification and treatment simulation to response monitoring, resistance prediction, and survivorship care. Dedicated chapters address validation, uncertainty, ethics, governance, and clinical implementation. Readers gain a clear understanding of how computational models can be translated into clinically meaningful decision-support tools. The book serves as a valuable resource for researchers, clinicians, and students seeking to bridge computational innovation and real-world precision cancer care.
Autoren/Hrsg.
Weitere Infos & Material
Part I. Conceptual and Technical Foundations
1. Digital Twins and the Future of Precision Oncology
2. Defining the Cancer Digital Twin: Concepts, Boundaries, and Clinical Use Cases
3. Multimodal Data Foundations: Imaging, Pathology, Omics, Liquid Biopsy, EHR, and Longitudinal Outcomes
4. Computational Modeling and AI Approaches: Mechanistic, Data-Driven, Hybrid, and Foundation Models
5. Building Dynamic Patient-Specific Twins: Data Integration, Updating, Feedback, and Uncertainty
Part II. Biological and Clinical Applications
6. Modeling Tumor Growth, Evolution, Metastasis, and the Tumor Microenvironment
7. Digital Twins for Screening, Diagnosis, and Risk Stratification
8. Digital Twins for Radiotherapy, Surgery, and Image-Guided Adaptive Local Treatment
9. Digital Twins for Systemic Therapy, Immuno-Oncology, and Resistance Prediction
10. Response Monitoring, Recurrence Prediction, Clinical Trials, and Survivorship Care
Part III. Translation, Implementation, and Governance
11. Validation, Clinical Utility, Reporting, and Regulatory-Grade Evidence
12. Workflow Integration, Ethics, Governance, Equity, and Future Directions




